Developing a stem-cell derived kidney for end-stage renal disease

About the project:

The long-term objective of this disease team is to develop a transplantable auxiliary kidney from human pluripotent stem cells. Such an engineered tissue would need to provide renal replacement superior to dialysis and with fewer complications.

The initial target population would be elderly (>70 years) end stage renal failure patients for whom dialysis is counter-indicated and for whom a transplant is not available. If successful, this may be more widely applicable for a wider end stage renal failure patient population.

Research theme: reBUILD

Tissue of interest: Kidney

Explore more reNEW Melbourne projects

Proudly in partnership with

The Novo Nordisk Foundation Center for Stem Cell Medicine, reNEW, is supported by a Novo Nordisk Foundation grant number NNF21CC0073729​​